Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

GSK is laying out €250 million to bolster vaccine manufacturing with a new facility to help make free-dried shots, including for shingles and RSV.

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...

- Adaptimmune plans to be IND-ready in 2023 with a PRAME targeted TCR T-cell therapy - - Adaptimmune and GSK will work collaboratively to ensure continuity for patients in ongoing clinical trials ...

Big Pharma firm GSK plans to invest up to $800 million to expand its manufacturing operations in Pennsylvania and create 200 new jobs.

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now.In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other ...